STOCK TITAN

Evogene Ltd. (EVGN) SEC Filings, Jul-Aug 2025

EVGN NASDAQ

Evogene Ltd. filings document a foreign private issuer whose disclosures are centered on computational chemistry, ChemPass AI™, and small-molecule product development for pharmaceutical and agricultural markets. Form 6-K reports furnish quarterly and annual financial results, unaudited consolidated financial statements, operating and financial review materials, and presentations incorporated by reference into registration statements.

The filing record also covers material agreements and corporate events tied to Evogene's subsidiaries and platform strategy, including Biomica's BMC128 licensing disclosure, management changes, Nasdaq minimum-bid-price correspondence, and capital-structure disclosures through Form F-3 and Form S-8 references. These documents describe governance and financing context for EVGN ordinary shares and the company's operating subsidiaries.

Rhea-AI Summary

Evogene Ltd. reported that its Annual General Meeting of Shareholders, originally convened on August 11, 2025, was adjourned for one week due to a lack of quorum, meaning not enough shares were represented to hold a valid meeting. The meeting is scheduled to be reconvened on Monday, August 18, 2025 at 3:00 p.m. (Israel time) at the company’s executive offices in Rehovot, Israel.

The report also states that its content is incorporated by reference into Evogene’s existing registration statements on Form F-3 and multiple Form S-8 filings, so this update becomes part of those documents for U.S. securities law purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.31%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.82%
Tags
current report

FAQ

How many Evogene Ltd. (EVGN) SEC filings are available on StockTitan?

StockTitan tracks 72 SEC filings for Evogene Ltd. (EVGN), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Evogene Ltd. (EVGN)?

The most recent SEC filing for Evogene Ltd. (EVGN) was filed on November 16, 2026.